pegylated SN-38 conjugate PLX038
Term · Oncology and biomedicine · MLC-T-ONC-015932
A pegylated conjugate of SN-38 (7-ethyl-10-hydroxy-camptothecin), a biologically active metabolite of the prodrug irinotecan, with potential antineoplastic activity. Upon administration, the proprietary linker slowly releases SN-38 from the pegylated SN-38 conjugate PLX038. SN-38 binds to and inhibits topoisomerase I by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks, inhibition of DNA replication, and apoptosis. Compared with irinotecan, this formulation allows higher accumulation in solid tumors due to its nanoparticle size and long half-life.
| Identifier | MLC-T-ONC-015932 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | pegylated SN-38 PLX038 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015932",
"term": "pegylated SN-38 conjugate PLX038",
"field": "Oncology and biomedicine",
"definition": "A pegylated conjugate of SN-38 (7-ethyl-10-hydroxy-camptothecin), a biologically active metabolite of the prodrug irinotecan, with potential antineoplastic activity. Upon administration, the proprietary linker slowly releases SN-38 from the pegylated SN-38 conjugate PLX038. SN-38 binds to and inhibits topoisomerase I by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks, inhibition of DNA replication, and apoptosis. Compared with irinotecan, this formulation allows higher accumulation in solid tumors due to its nanoparticle size and long half-life.",
"synonyms": [
"pegylated SN-38 PLX038"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pegylated-sn-38-conjugate-plx038/"
}
Record 12,877 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.